These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 20662707)
21. [Acute lymphoblastic leukemia complicated with tumor lysis syndrome--four cases report]. He H; Li C; Han M Zhonghua Xue Ye Xue Za Zhi; 1999 Jun; 20(6):310-2. PubMed ID: 11721390 [TBL] [Abstract][Full Text] [Related]
22. [Tumor lysis syndrome]. Jeddi R; Ben Abdennebi Y; Allani B; Belakhal R; Aissaoui L; Ben Abid H; Ali ZB; Meddeb B Tunis Med; 2007 Feb; 85(2):174-6. PubMed ID: 17665670 [TBL] [Abstract][Full Text] [Related]
23. Continuous veno-venous hemodiafiltration for the treatment of spontaneous tumor lysis syndrome complicated by acute renal failure and severe hyperuricemia. Agha-Razii M; Amyot SL; Pichette V; Cardinal J; Ouimet D; Leblanc M Clin Nephrol; 2000 Jul; 54(1):59-63. PubMed ID: 10939758 [TBL] [Abstract][Full Text] [Related]
27. A tumor lysis-like syndrome during therapy of visceral leishmaniasis. Liberopoulos E; Alexandridis G; Elisaf M Ann Clin Lab Sci; 2002; 32(4):419-21. PubMed ID: 12458897 [TBL] [Abstract][Full Text] [Related]
28. Rasburicase for the treatment of tumor lysis in hematological malignancies. Malaguarnera G; Giordano M; Malaguarnera M Expert Rev Hematol; 2012 Feb; 5(1):27-38. PubMed ID: 22272702 [TBL] [Abstract][Full Text] [Related]
29. Tumor lysis syndrome: new challenges and recent advances. Wilson FP; Berns JS Adv Chronic Kidney Dis; 2014 Jan; 21(1):18-26. PubMed ID: 24359983 [TBL] [Abstract][Full Text] [Related]
30. The role of hypercytokinemia in the pathophysiology of tumor lysis syndrome (TLS) and the treatment with continuous hemodiafiltration using a polymethylmethacrylate membrane hemofilter (PMMA-CHDF). Nakamura M; Oda S; Sadahiro T; Hirayama Y; Tateishi Y; Abe R; Hirasawa H Transfus Apher Sci; 2009 Feb; 40(1):41-7. PubMed ID: 19109071 [TBL] [Abstract][Full Text] [Related]
33. The analysis of the risks for the development of tumour lysis syndrome in children. Kopecna L; Dolezel Z; Osvaldova Z; Starha J; Hrstkova H Bratisl Lek Listy; 2002; 103(6):206-9. PubMed ID: 12448566 [TBL] [Abstract][Full Text] [Related]
35. [Tumor lysis syndrome in a dog]. Piek CJ; Teske E Tijdschr Diergeneeskd; 1996 Feb; 121(3):64-6. PubMed ID: 8711720 [TBL] [Abstract][Full Text] [Related]
36. Risk evaluation, prophylaxis, and treatment of tumor lysis syndrome: consensus of an Italian expert panel. Pession A; Masetti R; Gaidano G; Tosi P; Rosti G; Aglietta M; Specchia G; Porta F; Pane F Adv Ther; 2011 Aug; 28(8):684-97. PubMed ID: 21779956 [TBL] [Abstract][Full Text] [Related]
37. Marked hyperuricemia with acute renal failure: need to consider occult malignancy and spontaneous tumour lysis syndrome. Agnani S; Gupta R; Atray NK; Vachharajani TJ Int J Clin Pract; 2006 Mar; 60(3):364-6. PubMed ID: 16494656 [TBL] [Abstract][Full Text] [Related]
38. Tumor lysis syndrome: a systematic review of case series and case reports. Firwana BM; Hasan R; Hasan N; Alahdab F; Alnahhas I; Hasan S; Varon J Postgrad Med; 2012 Mar; 124(2):92-101. PubMed ID: 22437219 [TBL] [Abstract][Full Text] [Related]
39. Rasburicase: an innovative new treatment for hyperuricemia associated with tumor lysis syndrome. Brant JM Clin J Oncol Nurs; 2002; 6(1):12-6. PubMed ID: 11842483 [TBL] [Abstract][Full Text] [Related]
40. Incidence and pathogenesis of tumor lysis syndrome. Locatelli F; Rossi F Contrib Nephrol; 2005; 147():61-68. PubMed ID: 15604606 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]